ROUSSEL CLEMENT: Open Payments
NPI 1710977913 · GROVES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 24 payments from 10 companies in 2025. Trend: 2023 $1,089 · 2024 $627 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $173 |
| PFIZER INC. | 4 | $92 |
| ABBVIE INC. | 3 | $73 |
| Indivior Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $32 |
| Dexcom, Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Smith+Nephew, Inc. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: Kerendia, ELIQUIS, UBRELVY, SUBLOCADE, Veozah, Dexcom G6 Transmitter, Rybelsus, FARXIGA.
Industry payments across TX — which companies pay providers there.
